SCHEMBL25073050

SCHEMBL25073050

NS(=O)(=O)c1cnc(-c2ccc(F)cc2)s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 4/20 0.45
▸ CA9 Q16790 4/20 0.45
▸ CA12 O43570 3/20 0.45
▸ CA1 P00915 3/20 0.45
▸ PTPN11 Q06124 1/20 0.45
▸ PTGS2 P35354 8/20 0.42
▸ CA4 P22748 1/20 0.42
▸ CA5A P35218 1/20 0.42
▸ CA5B Q9Y2D0 1/20 0.42
▸ PTGS1 P23219 6/20 0.41
▸ CDK5 Q00535 2/20 0.41
▸ CDK5R1 Q15078 2/20 0.41
▸ GCK P35557 1/20 0.41
▸ GCKR Q14397 1/20 0.41
▸ CCNE1 P24864 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ LOXL2 Q9Y4K0 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25072475 0.83 PTPN11 (0.42) CA2CA9CA12CA1PTPN11
SCHEMBL9096579 0.83 CA2 (0.46) CA2CA9CA12CA1CA4
SCHEMBL25073052 0.75 APP (0.40) PTPN11MAOBKDM4ENPC1ALDH1A1
SCHEMBL25073315 0.75 KMT2A (0.49) PTPN11PTGS2KDM4ENPC1ALDH1A1
SCHEMBL25073280 0.73 PTPN11 (0.45) CA2CA1PTPN11GCKGCKR
SCHEMBL23367954 0.73 APP (0.44) PTPN11KDM4ENPC1ALDH1A1MAPT
SCHEMBL25072418 0.71 PTPN11 (0.44) PTPN11PTGS1KDM4ENPC1ALDH1A1
SCHEMBL2090443 0.71 PTPN11 (0.44) PTPN11KDM4ENPC1ALDH1A1CYP1A2
SCHEMBL18118201 0.70 CA1 (0.56) CA2CA9CA12CA1PTPN11
SCHEMBL31341150 0.70 PTPN11 (0.58) PTPN11CDK5CDK2NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023023310-A1 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. (US) 2023-02-23 — — WO disclosed
Send feedback